双胎生长不一致对子痫前期的影响:基于绒毛膜性的分析
这项单中心回顾性研究纳入2122例双胎妊娠,发现生长不一致(双胎出生体重差≥20%)总体患病率为17.6%。在双绒毛膜双胎中,生长不一致与妊娠期高血压-子痫前期风险升高相关,且风险随不一致程度增加呈剂量反应关系;单绒毛膜双胎中未见显著关联。
要点
- 双绒毛膜双胎生长不一致与子痫前期风险升高独立相关。
- 双绒毛膜双胎生长不一致程度每增加10%,子痫前期风险进一步升高。
- 单绒毛膜双胎中生长不一致与子痫前期无显著关联。
核心结论
- 双胎生长不一致与双绒毛膜双胎的子痫前期风险升高相关,但与单绒毛膜双胎无显著关联。
- 在双绒毛膜双胎中,子痫前期风险随生长不一致程度增加而显著升高,呈剂量反应关系。
研究设计与样本
- 回顾性单中心研究,纳入2013年1月至2016年6月期间某三级医院收治的2122例双胎妊娠孕妇。
- 生长不一致定义为双胎出生体重差≥20%。
主要发现
- 生长不一致的患病率为17.6%。
- 在全部研究对象中,生长不一致与妊娠期高血压-子痫前期风险升高相关。
- 双绒毛膜双胎中,生长不一致与妊娠期高血压-子痫前期风险升高相关(AOR 1.84;95%CI 1.26-2.67),与子痫前期风险升高相关(AOR 1.82;95%CI 1.21-2.73),包括轻度子痫前期(AOR 1.86;95%CI 1.02-3.37)、重度子痫前期(AOR 1.78;95%CI 1.06-2.97;P<.05)和早发型子痫前期(AOR 2.98;95%CI 1.40-6.32)。
- 双绒毛膜双胎中,生长不一致程度每增加10%,妊娠期高血压-子痫前期风险升高(AOR 1.20;95%CI 1.02-1.41),子痫前期风险升高(AOR 1.24;95%CI 1.04-1.48),包括重度子痫前期(AOR 1.28;95%CI 1.04-1.59)和早发型子痫前期(AOR 1.47;95%CI 1.08-2.00)。
- 单绒毛膜双胎中,生长不一致与妊娠期高血压-子痫前期风险无显著关联。
临床怎么用
- 对双绒毛膜双胎妊娠,应关注生长不一致程度,将其作为子痫前期风险评估的参考因素。
- 单绒毛膜双胎生长不一致对子痫前期的预测价值有限,需结合其他临床指标综合评估。
局限性
- 本研究为单中心回顾性研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite extensive investigations over the last decade, preeclampsia remains an unpredictable pregnancy complication causing perinatal morbidity and mortality worldwide, particularly in twin pregnancies. OBJECTIVE: This study aimed to determine the relationship between growth discordance in twin pregnancies and the risk for preeclampsia based on chorionicity. STUDY DESIGN: This was a retrospective single-center study that included 2122 women with twin pregnancies who were admitted to a tertiary hospital between January 2013 and June 2016. Growth discordance was defined as twin birthweight difference ≥20%. Logistic regression models were used to analyze the association between growth discordance and risk for gestational hypertension-preeclampsia in all subjects. Stratified sampling by twin chorionicity (dichorionic and monochorionic) was also conducted. Further analysis was performed to estimate the association between the degree of growth discordance and gestational hypertension-preeclampsia risk in monochorionic and dichorionic twin pregnancies. RESULTS: The prevalence of growth discordance was 17.6%. In all subjects, growth discordance was associated with increased risk for gestational hypertension-preeclampsia. After stratification by twin chorionicity, growth discordance was associated with an increased risk for gestational hypertension preeclampsia (adjusted odds ratio [AOR], 1.84; 95% confidence interval [CI], 1.26-2.67) and preeclampsia (AOR, 1.82; 95% CI, 1.21-2.73), including mild preeclampsia (AOR, 1.86; 95% CI, 1.02-3.37), severe preeclampsia (AOR, 1.78; 95% CI, 1.06-2.97; P<.05), and early-onset preeclampsia (AOR, 2.98; 95% CI, 1.40-6.32), in the dichorionic twin pregnancy group; however, no significant association was found in the monochorionic twin pregnancy group. A 10% increment of growth discordance in the dichorionic twin pregnancy group was associated with an elevated risk for gestational hypertension preeclampsia (AOR, 1.20; 95% CI, 1.02-1.41) and preeclampsia (AOR, 1.24; 95% CI, 1.04-1.48), including severe preeclampsia (AOR, 1.28; 95% CI, 1.04-1.59) and early-onset preeclampsia (AOR, 1.47; 95% CI, 1.08-2.00), but no significant association was found in the monochorionic twin pregnancy group. CONCLUSION: Growth discordance is associated with an increased risk for preeclampsia in dichorionic but not in monochorionic twin pregnancy. In addition, the prevalence of preeclampsia increases significantly with increasing degree of growth discordance, reflecting a dose-response relationship in dichorionic twin pregnancy.
引用
- Qiao P, Zhao Y, Jiang X, et al. Impact of growth discordance in twins on preeclampsia based on chorionicity. Am J Obstet Gynecol. 2020. PMID: 32247845. doi:10.1016/j.ajog.2020.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。